Patents Assigned to Blanchett Rockefeller Neurosciences Institute
  • Alzheimer's disease diagnosis based on mitogen-activated protein kinase phosphorylation
    Patent number: 9188595
    Abstract: A method of diagnosing Alzheimer's disease in a patient comprises determining whether the phosphorylation level of an indicator protein in cells of the patient after stimulus with an activator compound is abnormally elevated as compared to a basal phosphorylation level, the indicator protein being e.g. Erk1/2 and the activator compound being e.g. bradykinin.
    Type: Grant
    Filed: March 22, 2010
    Date of Patent: November 17, 2015
    Assignee: Blanchett Rockefeller Neurosciences Institute
    Inventors: Wei-Qin Zhao, Daniel L. Alkon